SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Romeo who wrote (5970)1/26/1999 9:35:00 PM
From: Jan P   of 6136
 
John,

I agree and am very upset about the deal. I had a wild mood swing starting this morning when I read the anecdotal but thrilling story
about AG3340's use with the prostate cancer patient (by the way, I thank the poster of that message). Then, low and behold, as I go to look for earnings, I find this sell out. I would infinitely prefer having WLA hold a 19% stake in Agouron than seeing its programs submerged in a behemoth conglomerate for a 25 cent premium.

I plan to vote no, and I hope many others do too.

Jan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News